Clinical efficacy observation of emergency internal medicine in elderly patients with severe heart failure
老年重症心力衰竭急诊内科临床疗效观察

摘要

目的 探究急诊内科在对老年重症心力衰竭患者治疗中的效果。方法 在2022年6月至2023年4月本院老年重症心力衰竭患者中选择76例为对象，按照数字表随机排序划分对照组（38例，按照常规方案进行治疗）和观察组（38例，服用美托洛尔、厄贝沙坦氢氯噻嗪治疗）。对比治疗效果。结果 观察组治疗后心功能高于对照组，P<0.05。观察组心衰标志物水平低于对照组，P<0.05。观察组整体治疗有效率以及血流动力指标高于对照组，P<0.05。结论 在对老年重症心力衰竭患者进行急诊内科治疗时，按照美托洛尔、施厄贝沙坦氢氯噻嗪联合辅助治疗，可以迅速提升患者心功能，且并发症少，有利于患者恢复。

Abstract

Objective To explore the effectiveness of emergency internal medicine in the treatment of elderly patients with severe heart failure.
Methods From June 2022 to April 2023, 76 elderly patients with severe heart failure in our hospital were selected as the subjects and randomly divided into a control group (38 cases, treated according to the conventional plan) and an observation group (38 cases, treated with metoprolol and irbesartan hydrochlorothiazide) according to a numerical table. Compare treatment effects.
Results The cardiac function of the observation group was higher than that of the control group (P<0.05). The level of heart failure markers in the observation group was lower than that in the control group, P<0.05. The overall effective rate and hemodynamic indexes of observation group were higher than those of control group (P<0.05).
Conclusion   When emergency internal medicine treatment is performed on elderly patients with severe heart failure, the combination of metoprolol, sulbactam, and hydrochlorothiazide as adjunctive therapy can quickly improve the patient's heart function with fewer complications, which is beneficial for patient recovery.